MeSH term | MeSH ID | Detail |
---|---|---|
Otitis Media | D010033 | 12 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
MeSH term | MeSH ID | Detail |
---|---|---|
Otitis Media | D010033 | 12 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Venkateswaran S et al. | Protective effect of Livex, a herbal formulation against erythromycin estolate induced hepatotoxicity in rats. | 1997 | J Ethnopharmacol | pmid:9292408 |
Halperin SA et al. | Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. | 1997 | Pediatrics | pmid:9200361 |
Adam D and Scholz H | Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group. | 1996 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:8922570 |
Potthast H et al. | [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state]. | 1995 | Pharmazie | pmid:7886126 |
Gilbert FI | Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. 1962. | 1995 | Hawaii Med J | pmid:7642362 |
Thibault N et al. | Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocyte couplets. | 1993 | J. Hepatol. | pmid:8151096 |
Snellman LW et al. | Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. | 1993 | Pediatrics | pmid:8502522 |
Cachet T et al. | Analysis of erythromycin estolate by liquid chromatography. | 1992 Oct-Dec | J Pharm Biomed Anal | pmid:1298393 |
Villa P et al. | Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes. | 1992 | Toxicology | pmid:1609428 |
Hillyer D | Is erythromycin indicated in pregnancy? | 1992 | RN | pmid:1594870 |
Hoppe JE | Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. The Erythromycin Study Group. | 1992 | Pediatr. Infect. Dis. J. | pmid:1565532 |
Saiz Santos S and Montero López L | [Hepatotoxicity from erythromycin estolate]. | 1992 | Aten Primaria | pmid:1467424 |
Amacher DE et al. | Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. | 1991 | Antimicrob. Agents Chemother. | pmid:1656856 |
Ramin U and Wollmann H | [Problems in the determination of water content of lubomycin B capsules]. | 1990 | Pharmazie | pmid:2080216 |
Bocka JJ | Pertussis in an infant. | 1989 Jul-Aug | J Emerg Med | pmid:2689510 |
Klein MD | Streptococcal pharyngitis in children. | 1989 | Pediatr Emerg Care | pmid:2690022 |
Davila JC et al. | Protective effect of flavonoids on drug-induced hepatotoxicity in vitro. | 1989 | Toxicology | pmid:2756528 |
Stubbs C and Kanfer I | Variability in the absorption and disposition of erythromycin estolate in humans. | 1989 | J Pharm Sci | pmid:2778669 |
Farre M | Erythromycin propionate and estolate. | 1988 | Lancet | pmid:2898648 |
Laperrière H and Lefebvre J | Persistence of inclusion conjunctivitis after oral erythromycin therapy. | 1988 | CMAJ | pmid:3179892 |